Search research articles
Contact Us
Filters
Showing results (21-30 of 57) with videos related to
Page
of 6
Sort By:
Diabetes, Obesity & Metabolism
|
March 28, 2023
Ultra rapid lispro showed greater reduction in postprandial glucose versus Humalog in children, adolescents and adults with type 1 diabetes mellitus
Ronnie Aronson, Torben Biester, Jennifer Leohr, et al.
Diabetes Technology & Therapeutics
|
March 8, 2021
Declining Frequency of Acute Complications Associated with Tubeless Insulin Pump Use: Data from 2,911 Patients in the German/Austrian Diabetes Patienten Verlaufsdokumentation Registry
Torben Biester, Anke Schwandt, Bettina Heidtmann, et al.
The Journal of Pediatrics
|
December 17, 2016
Liraglutide in an Adolescent Population with Obesity: A Randomized, Double-Blind, Placebo-Controlled 5-Week Trial to Assess Safety, Tolerability, and Pharmacokinetics of Liraglutide in Adolescents Aged 12-17 Years
Thomas Danne, Torben Biester, Kerstin Kapitzke, et al.
Pediatric Diabetes
|
January 29, 2014
Insulin degludec's ultra-long pharmacokinetic properties observed in adults are retained in children and adolescents with type 1 diabetes
Torben Biester, Sarah Blaesig, Kerstin Remus, et al.
Monatsschrift Kinderheilkunde : Organ Der Deutschen Gesellschaft Fur Kinderheilkunde
|
January 13, 2021
[Is it possible to prevent diabetic ketoacidosis at diagnosis of pediatric type 1 diabetes? Lessons from the COVID-19 pandemic]
Kirsten Mönkemöller, Clemens Kamrath, Johanna Hammersen, et al.
Pediatric Diabetes
|
February 16, 2018
Long-term study of tubeless insulin pump therapy compared to multiple daily injections in youth with type 1 diabetes: Data from the German/Austrian DPV registry
Thomas Danne, Anke Schwandt, Torben Biester, et al.
Pediatric Diabetes
|
August 2, 2020
Lipoatrophy in children, adolescents and adults with insulin pump treatment: Is there a beneficial effect of insulin glulisine?
Olga Kordonouri, Torben Biester, Jürgen Weidemann, et al.
Diabetes Technology & Therapeutics
|
September 5, 2023
Expected Basal Insulin Requirement During Continuous Subcutaneous Insulin Infusion Therapy by Age Group, Sex, and Body Mass Index, Based on 25,718 Young People with Type 1 Diabetes in the DPV Registry
Torben Biester, Alexander Eckert, Marianne Becker, et al.
The Lancet. Diabetes & Endocrinology
|
December 19, 2024
Hybrid closed-loop insulin therapy and risk of severe hypoglycaemia and diabetic ketoacidosis in young people (aged 2-20 years) with type 1 diabetes: a population-based study
Beate Karges, Joachim Rosenbauer, Anna Stahl-Pehe, et al.
Journal of Diabetes
|
November 8, 2024
Clinical characteristics, treatment, and treatment switch after molecular-genetic classification in individuals with maturity-onset diabetes of the young: Insights from the multicenter real-world DPV registry
Stefanie Lanzinger, Katharina Laubner, Katharina Warncke, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 57) with videos related to
Sort By:
Page
of 6
Diabetes, Obesity & Metabolism
|
March 28, 2023
Ultra rapid lispro showed greater reduction in postprandial glucose versus Humalog in children, adolescents and adults with type 1 diabetes mellitus
Ronnie Aronson, Torben Biester, Jennifer Leohr, et al.
Diabetes Technology & Therapeutics
|
March 8, 2021
Declining Frequency of Acute Complications Associated with Tubeless Insulin Pump Use: Data from 2,911 Patients in the German/Austrian Diabetes Patienten Verlaufsdokumentation Registry
Torben Biester, Anke Schwandt, Bettina Heidtmann, et al.
The Journal of Pediatrics
|
December 17, 2016
Liraglutide in an Adolescent Population with Obesity: A Randomized, Double-Blind, Placebo-Controlled 5-Week Trial to Assess Safety, Tolerability, and Pharmacokinetics of Liraglutide in Adolescents Aged 12-17 Years
Thomas Danne, Torben Biester, Kerstin Kapitzke, et al.
Pediatric Diabetes
|
January 29, 2014
Insulin degludec's ultra-long pharmacokinetic properties observed in adults are retained in children and adolescents with type 1 diabetes
Torben Biester, Sarah Blaesig, Kerstin Remus, et al.
Monatsschrift Kinderheilkunde : Organ Der Deutschen Gesellschaft Fur Kinderheilkunde
|
January 13, 2021
[Is it possible to prevent diabetic ketoacidosis at diagnosis of pediatric type 1 diabetes? Lessons from the COVID-19 pandemic]
Kirsten Mönkemöller, Clemens Kamrath, Johanna Hammersen, et al.
Pediatric Diabetes
|
February 16, 2018
Long-term study of tubeless insulin pump therapy compared to multiple daily injections in youth with type 1 diabetes: Data from the German/Austrian DPV registry
Thomas Danne, Anke Schwandt, Torben Biester, et al.
Pediatric Diabetes
|
August 2, 2020
Lipoatrophy in children, adolescents and adults with insulin pump treatment: Is there a beneficial effect of insulin glulisine?
Olga Kordonouri, Torben Biester, Jürgen Weidemann, et al.
Diabetes Technology & Therapeutics
|
September 5, 2023
Expected Basal Insulin Requirement During Continuous Subcutaneous Insulin Infusion Therapy by Age Group, Sex, and Body Mass Index, Based on 25,718 Young People with Type 1 Diabetes in the DPV Registry
Torben Biester, Alexander Eckert, Marianne Becker, et al.
The Lancet. Diabetes & Endocrinology
|
December 19, 2024
Hybrid closed-loop insulin therapy and risk of severe hypoglycaemia and diabetic ketoacidosis in young people (aged 2-20 years) with type 1 diabetes: a population-based study
Beate Karges, Joachim Rosenbauer, Anna Stahl-Pehe, et al.
Journal of Diabetes
|
November 8, 2024
Clinical characteristics, treatment, and treatment switch after molecular-genetic classification in individuals with maturity-onset diabetes of the young: Insights from the multicenter real-world DPV registry
Stefanie Lanzinger, Katharina Laubner, Katharina Warncke, et al.
Page
of 6